Characterizing Long COVID: Deep Phenotype of a Complex Condition

Rachel Deer(The University of Texas Medical Branch at Galveston), Madeline Rock(The University of Texas Medical Branch at Galveston), Nicole Vasilevsky(University of Colorado Anschutz Medical Campus), Leigh Carmody(Jackson Laboratory), Halie M. Rando(University of Colorado Anschutz Medical Campus), Alfred Anzalone(University of Nebraska Medical Center), Marc D. Basson(University of North Dakota), Tellen D. Bennett(University of Colorado Anschutz Medical Campus), Timothy Bergquist(Sage Bionetworks), Eilis Boudreau(Oregon Health & Science University), Carolyn T. Bramante(University of Minnesota Medical Center), James Brian Byrd(University of Michigan), Tiffany J. Callahan(University of Colorado Anschutz Medical Campus), Lauren Chan(Oregon State University), Haitao Chu(University of Minnesota), Christopher G. Chute(Johns Hopkins University), Ben Coleman(University of Connecticut), Hannah Davis(Patient-Led Research Collaborative), Joel Gagnier(University of Michigan), Casey S. Greene(University of Colorado Anschutz Medical Campus), William B. Hillegass(University of Mississippi Medical Center), Ramakanth Kavuluru(University of Kentucky), Wesley Kimble(West Virginia University), Farrukh M. Koraishy(Stony Brook University), Sebastian Köhler(Vienna Vaccine Safety Initiative), Chen Liang(University of South Carolina), Feifan Liu(University of Massachusetts Chan Medical School), Hongfang Liu(Mayo Clinic in Florida), Vithal Madhira, Charisse Madlock‐Brown(University of Tennessee Health Science Center), Nicolas Matentzoglu(European Bioinformatics Institute), Diego R. Mazzotti(University of Kansas Medical Center), Julie A. McMurry(University of Colorado Anschutz Medical Campus), Douglas McNair(Gates Foundation), Richard A. Moffitt(Stony Brook University), Teshamae Monteith(University of Miami), Ann M. Parker(Johns Hopkins University), Mallory Perry(Children's Hospital of Philadelphia), Emily Pfaff(University of North Carolina at Chapel Hill), Justin Reese(Lawrence Berkeley National Laboratory), Joel Saltz(Biomedical Informatics Research Center Antwerp), Robert A Schuff(Ochin), Anthony Solomonides(NorthShore University HealthSystem), Julian Solway(University of Chicago), Heidi Spratt(The University of Texas Medical Branch at Galveston), Gary S. Stein(University of Vermont), Anupam Sule(Trinity Health Oakland Hospital), Ümit Topaloĝlu(Wake Forest University), George D. Vavougios(University of Thessaly), Liwei Wang(Mayo Clinic in Florida), Melissa Haendel(University of Colorado Anschutz Medical Campus), Peter N. Robinson(University of Connecticut)
EBioMedicine
November 25, 2021
Cited by 210Open Access
Full Text

Abstract

BACKGROUND: Numerous publications describe the clinical manifestations of post-acute sequelae of SARS-CoV-2 (PASC or "long COVID"), but they are difficult to integrate because of heterogeneous methods and the lack of a standard for denoting the many phenotypic manifestations. Patient-led studies are of particular importance for understanding the natural history of COVID-19, but integration is hampered because they often use different terms to describe the same symptom or condition. This significant disparity in patient versus clinical characterization motivated the proposed ontological approach to specifying manifestations, which will improve capture and integration of future long COVID studies. METHODS: The Human Phenotype Ontology (HPO) is a widely used standard for exchange and analysis of phenotypic abnormalities in human disease but has not yet been applied to the analysis of COVID-19. FUNDING: We identified 303 articles published before April 29, 2021, curated 59 relevant manuscripts that described clinical manifestations in 81 cohorts three weeks or more following acute COVID-19, and mapped 287 unique clinical findings to HPO terms. We present layperson synonyms and definitions that can be used to link patient self-report questionnaires to standard medical terminology. Long COVID clinical manifestations are not assessed consistently across studies, and most manifestations have been reported with a wide range of synonyms by different authors. Across at least 10 cohorts, authors reported 31 unique clinical features corresponding to HPO terms; the most commonly reported feature was Fatigue (median 45.1%) and the least commonly reported was Nausea (median 3.9%), but the reported percentages varied widely between studies. INTERPRETATION: Translating long COVID manifestations into computable HPO terms will improve analysis, data capture, and classification of long COVID patients. If researchers, clinicians, and patients share a common language, then studies can be compared/pooled more effectively. Furthermore, mapping lay terminology to HPO will help patients assist clinicians and researchers in creating phenotypic characterizations that are computationally accessible, thereby improving the stratification, diagnosis, and treatment of long COVID. FUNDING: U24TR002306; UL1TR001439; P30AG024832; GBMF4552; R01HG010067; UL1TR002535; K23HL128909; UL1TR002389; K99GM145411.


Related Papers

No related papers found

Powered by citation graph analysis